BioSpace News Archive

Imara Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, today announced it has hired Willem H. Scheele, M.D., as Chief Medical Officer.

Celerion was recognized as a leader within the Small Pharmaceutical company group as well as a leader in the Overall group

Cunningham Panel Helps Physicians Diagnose Autoimmune-Related Neuropsychiatric Conditions including PANS/PANDAS

Potential to target GPRC5D in multiple myeloma patients relapsed after BCMA-targeted therapy

From the devastating impact of crime on families and cities, lost productivity, costs to employers and the economy, to staggering health care costs raising premiums and taxes, the impact of addiction in America amounts to $1.45 trillion dollars each year, a study newly released by Recovery Centers of America (RCA) shows.

Updates are focused on new research findings impacting care for cardiovascular disease and chronic kidney disease in people with diabetes

In February, the Sanctuary of Hope (SOH), a state-of-the-art facility that will provide expectant mothers in crisis and their children a safe space from which to build a strong foundation for a fulfilling life, began accepting referrals and applications for their program.

Whitehead Institute, the world-renowned nonprofit research institution dedicated to improving human health through basic biomedical research, has announced that Institute Director David C. Page — a Whitehead Institute Member since 1988 and Director since 2004 — will complete his current term as Director and President in summer 2020.

TTX-030 is the first anti-CD39 therapeutic to be studied in patients

NeurologyLive®, a digital and print multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, presents its most recent “Peer Exchange” panel discussion, “Advances in the Diagnosis and Management of Multiple Sclerosis.”